Form 8-K - Current report:
SEC Accession No. 0001654954-25-013412
Filing Date
2025-11-24
Accepted
2025-11-24 17:00:37
Documents
15
Period of Report
2025-11-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cvm_8k.htm   iXBRL 8-K 23018
2 SHAREHOLDER RIGHTS AGREEMENT cvm_ex4.htm EX-4 326386
  Complete submission text file 0001654954-25-013412.txt   525240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cvm-20251118.xsd EX-101.SCH 5014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20251118_lab.xml EX-101.LAB 14667
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20251118_cal.xml EX-101.CAL 895
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20251118_pre.xml EX-101.PRE 9272
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20251118_def.xml EX-101.DEF 2096
17 EXTRACTED XBRL INSTANCE DOCUMENT cvm_8k_htm.xml XML 3856
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 251514028
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)